Karachi, The Searle Company Limited ("Searle"), a prominent pharmaceutical company, has successfully concluded its right share issuance, with both directors and sponsors demonstrating robust participation. The company's latest financial report reveals that the right shares, declared on May 25, 2023, have been fully subscribed by the internal stakeholders.
The right issue, which was approved during a board of directors meeting held on May 25, 2023, saw notable subscriptions from Searle's directors and sponsors. The auditors have verified the subscription, as confirmed by the enclosed auditor certificate.
The funds received for the allotment of these right shares have been credited to the company's designated bank account at Al-Baraka Bank Pakistan, with account number 0105337710033. The total amount collected from directors and sponsors for the allotment of 53.13% of the right shares amounts to a substantial sum of Rs. 2,258,233,075/-.
Among the notable contributors are prominent figures within the company. Mr. Munis Abdullah, a director, subscribed to 40,200 right shares, amounting to Rs. 1,407,000. Additionally, Mr. Adnan Asdar Ali and his spouse participated significantly, subscribing to 74,656 right shares, equivalent to Rs. 2,612,960. Mr. Zubair Razzak Palwala also emerged as a significant participant, with a subscription of 98,381 right shares, worth Rs. 3,443,335.
The company directors, in accordance with the Companies (Further Issue of Shares) Regulations, 2020, exercised their right to renounce their entitlement in favor of International Brands Limited ("IBL"), a sponsor of Searle. As a result, IBL successfully subscribed to the shares renounced by the directors, ultimately leading to the full subscription of these renounced shares.
Moreover, IBL, one of the sponsors of Searle, displayed substantial confidence in the company's prospects by subscribing to 64,225,622 right shares, amounting to a significant sum of Rs. 2,247,896,770.
This overwhelming response from both internal stakeholders and sponsors underscores the trust and optimism surrounding Searle's growth trajectory. The successful subscription to the right shares not only reflects the company's strong financial standing but also showcases the belief of key figures within the organization in its future potential.